Transcriptomics

Dataset Information

0

Novel dedifferentiated liposarcoma xenograft models reveal PTEN down regulation as a malignant signature and response to PI3K pathway inhibition


ABSTRACT: Liposarcoma is a type of soft tissue sarcoma, exhibiting poor survival and a high recurrence rate. Treatment is generally limited to surgery and radiation, emphasizing the need to understand this disease. Because very few in vivo and in vitro models can reproducibly recapitulate the human disease, we generated several xenograft models from surgically resected human dedifferentiated liposarcoma. Our study demonstrates that all xenografts recapitulate morphologic and gene expression characteristics of the patient tumors after continuous in vivo passages. Importantly, xenograftability is directly correlated with disease specific survival of liposarcoma patients. When treated with the PI3K/AKT/mTOR pathway inhibitor rapamycin alone or in combination with the multi-kinase inhibitor sorafenib, all xenografts responded with increased lipid content and a more differentiated gene expression profile.

ORGANISM(S): Homo sapiens

PROVIDER: GSE42975 | GEO | 2012/12/19

SECONDARY ACCESSION(S): PRJNA183994

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-12-19 | E-GEOD-42975 | biostudies-arrayexpress
2021-03-10 | GSE159659 | GEO
2021-09-17 | GSE184199 | GEO
| PRJNA670101 | ENA
2015-08-04 | E-GEOD-57750 | biostudies-arrayexpress
2015-08-04 | E-GEOD-57749 | biostudies-arrayexpress
2024-07-22 | GSE221493 | GEO
2024-07-22 | GSE221492 | GEO
| PRJNA914677 | ENA
| PRJNA914687 | ENA